Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| 1 |
Altria Group
MO
|
+$451M |
| 2 |
Grayscale Bitcoin Trust
GBTC
|
+$270M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$245M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$210M |
| 5 |
Infosys
INFY
|
+$123M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$52.9B |
| 2 |
Apple
AAPL
|
+$36.7B |
| 3 |
NVIDIA
NVDA
|
+$29.1B |
| 4 |
Amazon
AMZN
|
+$28.1B |
| 5 |
Meta Platforms (Facebook)
META
|
+$18.4B |
Sector Composition
| 1 | Technology | 21.49% |
| 2 | Financials | 10.71% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Industrials | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPHA
5726
Innate Pharma
IPHA
$189M
| $127K | ﹤0.01% |
44,124
-48,584
| -52% | -$140K |
|
5727
InnovAge Holding
INNV
$675M
| $127K | ﹤0.01% |
28,565
-46,989
| -62% | -$209K |
|
5728
Direxion Daily Aerospace & Defense Bull 3X Shares
DFEN
$337M
| $126K | ﹤0.01% |
4,719
-8,459
| -64% | -$225K |
|
|
CALT
5729
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $126K | ﹤0.01% |
5,986
+4,782
| +397% | +$100K |
|
5730
Innovator Laddered Allocation Power Buffer ETF
BUFF
$779M
| $125K | ﹤0.01% |
3,000
-3,000
| -50% | -$125K |
|
5731
Lantronix
LTRX
$179M
| $125K | ﹤0.01% |
35,153
-612,239
| -95% | -$2.18M |
|
|
GAN
5732
DELISTED
GAN Ltd
GAN
| $125K | ﹤0.01% |
98,410
-93,510
| -49% | -$119K |
|
5733
LXP Industrial Trust 6.5% Series C Cumulative Convertible Preferred Stock
LXP.PRC
$93.6M
| $125K | ﹤0.01% |
2,685
-2,717
| -50% | -$126K |
|
|
HITI
5734
High Tide
HITI
$311M
| $125K | ﹤0.01% |
+61,469
| New | +$125K |
|
5735
Valhi
VHI
$457M
| $124K | ﹤0.01% |
7,238
-11,444
| -61% | -$197K |
|
5736
Greenwich LifeSciences
GLSI
$152M
| $124K | ﹤0.01% |
6,230
+5,670
| +1,013% | +$113K |
|
|
CANF
5737
Can-Fite BioPharma
CANF
$10.2M
| $124K | ﹤0.01% |
55,807
-36,723
| -40% | -$81.5K |
|
5738
Origin Materials
ORGN
$77.5M
| $124K | ﹤0.01% |
242,671
-592,113
| -71% | -$302K |
|
5739
Envoy Medical
COCH
$28.4M
| $124K | ﹤0.01% |
31,541
+25,941
| +463% | +$102K |
|
|
XYF
5740
X Financial
XYF
$600M
| $124K | ﹤0.01% |
32,000
+3,800
| +13% | +$14.7K |
|
5741
Acrivon Therapeutics
ACRV
$49.1M
| $123K | ﹤0.01% |
17,243
-34,019
| -66% | -$243K |
|
5742
Swan Enhanced Dividend Income ETF
SCLZ
$13.6M
| $122K | ﹤0.01% |
+2,395
| New | +$122K |
|
5743
Fonar
FONR
$97M
| $122K | ﹤0.01% |
5,713
+1,501
| +36% | +$32.1K |
|
5744
Westwood Holdings Group
WHG
$157M
| $122K | ﹤0.01% |
9,871
+637
| +7% | +$7.85K |
|
5745
Nuveen Missouri Quality Municipal Income Fund
NOM
$26.6M
| $121K | ﹤0.01% |
11,901
-15,401
| -56% | -$156K |
|
5746
AEON Biopharma
AEON
$8.71M
| $121K | ﹤0.01% |
145
+95
| +190% | +$79.1K |
|
5747
ProShares Ultra Gold
UGL
$749M
| $121K | ﹤0.01% |
6,680
-8,136
| -55% | -$147K |
|
|
VIRX
5748
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $120K | ﹤0.01% |
118,016
-56,666
| -32% | -$57.8K |
|
5749
374Water
SCWO
$51.4M
| $120K | ﹤0.01% |
95,508
-223,800
| -70% | -$282K |
|
5750
Forafric Global
AFRI
$237M
| $120K | ﹤0.01% |
11,615
-10,127
| -47% | -$105K |
|